Henry Schein Inc. Hits New 52-Week High at $108.18 (HSIC)
Shares of Henry Schein (NASDAQ:HSIC) hit a new 52-week high during trading on Monday, StockRatingsNetwork reports. The stock traded as high as $108.18 and last traded at $107.94, with a volume of 305,324 shares trading hands. The stock had previously closed at $107.30.
HSIC has been the subject of a number of recent research reports. Analysts at ISI Group raised their price target on shares of Henry Schein from $106.00 to $110.00 in a research note to investors on Monday. They now have a “neutral” rating on the stock. Separately, analysts at Ned Davis Research downgraded shares of Henry Schein from a “buy” rating to a “neutral” rating in a research note to investors on Monday, September 30th. Finally, analysts at Zacks reiterated a “neutral” rating on shares of Henry Schein in a research note to investors on Monday, September 16th. They now have a $110.00 price target on the stock. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and two have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $96.14.
Henry Schein has a 52-week low of $73.35 and a 52-week high of $108.19. The stock has a 50-day moving average of $104.2 and a 200-day moving average of $98.88. The company has a market cap of $9.356 billion and a price-to-earnings ratio of 23.26.
Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, August 6th. The company reported $1.23 earnings per share for the quarter, meeting the analysts’ consensus estimate of $1.23. The company had revenue of $2.40 billion for the quarter, compared to the consensus estimate of $2.39 billion. During the same quarter last year, the company posted $1.11 earnings per share. Henry Schein’s revenue was up 8.6% compared to the same quarter last year. Analysts expect that Henry Schein will post $4.89 EPS for the current fiscal year.
Henry Schein, Inc is a provider of health care products and services to office-based practitioners. The Company conducts its business through two segments: healthcare distribution and technology.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.